Apellis Pharmaceuticals, Inc.

NasdaqGS:APLS 주식 보고서

시가총액: US$3.4b

Apellis Pharmaceuticals 미래 성장

Future 기준 확인 4/6

Apellis Pharmaceuticals (는) 각각 연간 72.1% 및 17.9% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 69.9% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 -1.7% 로 예상됩니다.

주요 정보

72.1%

수익 성장률

69.9%

EPS 성장률

Biotechs 수익 성장28.4%
매출 성장률17.9%
향후 자기자본 수익률-1.7%
애널리스트 커버리지

Good

마지막 업데이트21 Nov 2024

최근 미래 성장 업데이트

Recent updates

Would Apellis Pharmaceuticals (NASDAQ:APLS) Be Better Off With Less Debt?

Oct 18
Would Apellis Pharmaceuticals (NASDAQ:APLS) Be Better Off With Less Debt?

Apellis Pharmaceuticals: Assessing The Impact Of The Negative CHMP Opinion

Oct 01

Investors Aren't Buying Apellis Pharmaceuticals, Inc.'s (NASDAQ:APLS) Revenues

Sep 27
Investors Aren't Buying Apellis Pharmaceuticals, Inc.'s (NASDAQ:APLS) Revenues

Apellis: Rare Kidney Disease Data Leads To Possible First To Market

Aug 09

Health Check: How Prudently Does Apellis Pharmaceuticals (NASDAQ:APLS) Use Debt?

Jul 12
Health Check: How Prudently Does Apellis Pharmaceuticals (NASDAQ:APLS) Use Debt?

What Apellis Pharmaceuticals, Inc.'s (NASDAQ:APLS) P/S Is Not Telling You

May 30
What Apellis Pharmaceuticals, Inc.'s (NASDAQ:APLS) P/S Is Not Telling You

It's Probably Less Likely That Apellis Pharmaceuticals, Inc.'s (NASDAQ:APLS) CEO Will See A Huge Pay Rise This Year

May 30
It's Probably Less Likely That Apellis Pharmaceuticals, Inc.'s (NASDAQ:APLS) CEO Will See A Huge Pay Rise This Year

Apellis Pharmaceuticals Strives For Recovery Despite Syfovre Setbacks

May 14

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 09
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Apellis Pharmaceuticals: Eye Disease Drug Syfovre On Comeback Trail - But Risks Remain

Feb 16

With A 55% Price Drop For Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) You'll Still Get What You Pay For

Jul 19
With A 55% Price Drop For Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) You'll Still Get What You Pay For

Analysts Are Betting On Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) With A Big Upgrade This Week

May 13
Analysts Are Betting On Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) With A Big Upgrade This Week

Is Apellis Pharmaceuticals (NASDAQ:APLS) Using Debt In A Risky Way?

Apr 18
Is Apellis Pharmaceuticals (NASDAQ:APLS) Using Debt In A Risky Way?

Is Apellis Pharmaceuticals (NASDAQ:APLS) Using Debt Sensibly?

Dec 14
Is Apellis Pharmaceuticals (NASDAQ:APLS) Using Debt Sensibly?

수익 및 매출 성장 예측

NasdaqGS:APLS - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/20261,118631058917
12/31/2025866-120-24321
12/31/2024761-211-91-14120
9/30/2024715-250-206-205N/A
6/30/2024629-333-409-408N/A
3/31/2024524-417-551-550N/A
12/31/2023397-529-596-595N/A
9/30/2023273-606-639-638N/A
6/30/2023185-657-625-623N/A
3/31/2023106-691-582-580N/A
12/31/202275-652-515-514N/A
9/30/2022113-634-486-485N/A
6/30/202297-638-501-500N/A
3/31/202281-702-522-521N/A
12/31/202167-746-564-563N/A
9/30/2021256-520-310-309N/A
6/30/2021251-460-245-240N/A
3/31/2021251-360-211-205N/A
12/31/2020251-345-166-160N/A
9/30/20201-536-389-385N/A
6/30/2020N/A-470-340-338N/A
3/31/2020N/A-423-285-284N/A
12/31/2019N/A-305-213-211N/A
9/30/2019N/A-228-175-174N/A
6/30/2019N/A-194-154-153N/A
3/31/2019N/A-156-145-144N/A
12/31/2018N/A-128-131-131N/A
9/30/2018N/A-109-102-102N/A
6/30/2018N/A-85N/A-80N/A
3/31/2018N/A-64N/A-61N/A
12/31/2017N/A-51N/A-47N/A
9/30/2017N/A-39N/A-38N/A
6/30/2017N/A-35N/A-33N/A
3/31/2017N/A-30N/A-28N/A
12/31/2016N/A-27N/A-26N/A
9/30/2016N/A-29N/A-27N/A
6/30/2016N/A-53N/A-24N/A
3/31/2016N/A-50N/A-21N/A
12/31/2015N/A-47N/A-19N/A
9/30/2015N/A-41N/A-14N/A
6/30/2015N/A-12N/A-14N/A
3/31/2015N/A-12N/A-12N/A
12/31/2014N/A-11N/A-10N/A

애널리스트 미래 성장 예측

수입 대 저축률: APLS 은 향후 3년 동안 수익을 낼 것으로 예상되며, 이는 절약률( 2.6% )보다 빠른 성장으로 간주됩니다.

수익 vs 시장: APLS (는) 향후 3년 동안 평균 시장 성장보다 높은 수익을 올릴 것으로 예상됩니다.

고성장 수익: APLS 향후 3년 내에 수익을 낼 것으로 예상됩니다.

수익 대 시장: APLS 의 수익(연간 17.9% ) US 시장( 9% 보다 빠르게 성장할 것으로 예상됩니다. 9% 연간).

고성장 수익: APLS 의 수익(연간 17.9% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: APLS (는) 3년 내에 수익성이 없을 것으로 예상됩니다.


성장 기업 발견